Novavax Inc. diskutieren
Novavax Inc.
WKN: A2PKMZ / Symbol: NVAX / Name: Novavax / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
5,63 €
0,45 %
Novavax (NASDAQ:NVAX) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $10.00 price target on the stock.
Ratings data for NVAX provided by MarketBeat
Novavax (NASDAQ:NVAX) had its price target raised by analysts at HC Wainwright from $10.00 to $11.00. They now have a "buy" rating on the stock.
Ratings data for NVAX provided by MarketBeat
Novavax (NASDAQ:NVAX) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $18.00 price target on the stock.
Ratings data for NVAX provided by MarketBeat
Novavax (NASDAQ:NVAX) was downgraded by analysts at Wall Street Zen from a "hold" rating to a "sell" rating.
Ratings data for NVAX provided by MarketBeat
Novavax (NASDAQ:NVAX) had its "buy" rating reaffirmed by analysts at B. Riley. They now have a $16.00 price target on the stock, down previously from $18.00.
Ratings data for NVAX provided by MarketBeat
Novavax (NASDAQ:NVAX) had its price target lowered by analysts at JPMorgan Chase & Co. from $7.00 to $6.00. They now have an "underweight" rating on the stock.
Ratings data for NVAX provided by MarketBeat
Neueste Beiträge
StockNews_com in Axcelis Technologies diskutieren